Annotation Detail for EXOC2
Basic Information
Top
| Pathway ID | Pathway Name |
|---|
| Diabetes pathways |
| Pathway ID | Pathway Name |
|---|
| 200012 | Insulin Pathway |
| 200046 | Arf6 trafficking events |
| Pathway ID | Pathway Name |
|---|
| P04393 | Ras Pathway |
| Pathway ID | Pathway Name |
|---|
| 500128 | Insulin Synthesis and Processing |
| Desease Name |
|---|
| Black vs red hair color |
| tanning |
| Black vs blond hair color |
| Desease Name |
|---|
| Tanning |
| Freckles |
| Black vs. red hair color |
| Black vs. blond hair color |
| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of EXOC2 mRNA | affects expression | 21346803
|
| C518576 |
2-methylbutyric acid 4-((1,3)dioxan-5-ylmethoxyimino)-8-(2-(4-hydroxy-6-oxo-tetrahydropyran-2-yl)ethyl -7-methyl-6-oxo-1,2,3,4,6,7,8,8a-octahydronaphthyl)heptanoate |
2-methylbutyric acid 4-((1,3)dioxan-5-ylmethoxyimino)-8-(2-(4-hydroxy-6-oxo-tetrahydropyran-2-yl)ethyl -7-methyl-6-oxo-1,2,3,4,6,7,8,8a-octahydronaphthyl)heptanoate results in decreased expression of EXOC2 mRNA | decreases expression | 17327690
|
| D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of EXOC2 mRNA | affects expression | 16483693
|
| D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of EXOC2 mRNA | decreases expression | 20106945
|
| C011890 |
kojic acid |
kojic acid results in increased expression of EXOC2 mRNA | increases expression | 16595896
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
4.10 | 18287403 |
| MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
2.05 | 20127859 20464547 |
| MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.84 | 6695378 |
| MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.56 | 19183758 |
| MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.00 | 20146248 17474063 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
1.78 | 16705839 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.13 | 20419170 |
| MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
4.50 | 18551238 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
2.04 | 21346803 18551238 |
| MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
2.07 | 16530937 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
2.82 | 20471113 |
| MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
3.28 | 16705839 |
| MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
2.14 | 20195826 21137059 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
kojic acid |
3.53 | 18544905 |
| MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
1.57 | 20064080 20464547 17053015 18569708 6695378 18816296 20135361 18520028 20869020 |
| MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.46 | 16381670 |
| MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
4.40 | 18551238 |
| MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
2.31 | 11141357 |
| MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
3.78 | 12819281 16049721 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.91 | 17292933 |
| MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
2.76 | 18551238 |
| MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
2.51 | 19755658 10029692 |
| MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.56 | 2093021 20155912 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
5.35 | 16049721 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
5.35 | 17053015 |
| MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
4.86 | 10091137 |
Drug Bank